United Biomedical is an international bio/pharmaceutical firm that uses technology, such as reverse genomics and synthetic peptide chemistry, combined with traditional pharmaceutical and therapeutic delivery systems. The company develops products to treat and prevent diseases by directing the immune system. It s proprietary designer peptides and monoclonal antibody technologies have been used to produce a line of blood screening diagnostics for diseases that affect 10% of the global population. The company uses technologies to develop patented products for use in vaccines and immunotherapeutics for the prevention of Alzheimer s disease, AIDS and certain allergies. Each of these project programs is in sponsorship in product development by the United States National Institutes of Health. Corporate headquarter are in Hauppauge, N.Y., with operational divisions in Taiwan, Beijing and Shanghai. The United States headquarters serves as the base for administration, product and clinical development and houses FDA-licensed and USDA-licensed biologics manufacturing facilities.